📰 Forward Looking Statements News
Page 142 - Forward Looking Statements News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking Statements. Real-time updates on events, politics, business and more.
October 17, 2023
From Serendipity to Rational Design Taking Molecular Glue Degraders to New Heights | October 2023 Forward-Looking Statements ...
October 17, 2023
Investor Presentation Third Quarter 2023 MERCANTILE BANK CORPORATION | 1 ...
October 17, 2023
Hancock Whitney Corporation today announced its financial results for the third quarter of 2023. Net income for the third quarter of 2023 totaled $97.7 million, or $1.12 per diluted common share ,...
October 17, 2023
Investor Presentation October 2023 Forward-Looking Statements Various statements made in this presentation...
October 16, 2023
Rock Tech Lithium Inc. (TSXV: RCK) (OTCQX: RCKTF) (FWB: RJIB) (WKN: A1XF0V) (the "Company" or "Rock Tech") is pleased to announce that it is applying for additional public funding from the German government. The German Federal Ministry for Economic Affairs and Climate Action ("BMWK") has recently released a new program in accordance with the EU Temporary Crisis and Transition Framework (TCTF) allowing the Company to apply for up to € 200million funding to rea...
October 16, 2023
SINGAPORE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) is pleased to announce that it has successfully advanced to Phase 2 of the largest incentive prize in history, XPRIZE "$100M Carbon Removal" Challenge (the “Challenge”). This challenge seeks innovative solutions to extract and sequester carbon dioxide from the atmosphere, fighting climate change and rebalancing Earth’s carb...
October 16, 2023
Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) Q2 2024 Earnings Call Transcript October 12, 2023 Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to today’s conference call to discuss Rocky Mountain Chocolate’s Financial Results for the Fiscal Second Quarter 2024. [Operator Instructions] As a reminder, this conference is being recorded. Joining us […]
October 16, 2023
Treatment with setrusumab (UX143) for at least 6 months resulted in 67% reduction in annualized fracture rate in patients with OI in Phase 2/3 Orbit study
October 16, 2023
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, has appointed...